Optibiotix Health Share Discussion Threads

[1bokke] 07/1/2019 07:26

Seems it's true about clouds and silver linings.. First day back at work and we get a great RNS, something good to ponder on in the traffic. :-)

[shrewdmole] 07/1/2019 07:23

Bernie

A quick search seems that zeon India is a subsidiary with parent company being Japanese so very strategic alliance given the market opportunity across the Far East as well as Asia.

[parob] 07/1/2019 07:23

From Elric's recent blog/chat with SOH:hTTps://lemminginvestors.blogspot.com/2018/12/optibiotix-health-chat-with-ceo-stephen_19.html?m=1Elric - Can you say when TATA's new product facility will be on stream - isn't it due to be finished in 2019?Stephen O'Hara - It's due at the start of 2019. I will be in India early next years as we finialise closing out a number of Indian companies, not just TATA. We are replicating what we have achieved in Europe in India, so will will have a manufacture, and developer (for LPGOS/SlimBiome) then a distributor, so what we are doing now is setting up the whole supply chain between the manufacturer, developer and distributor. What we hope you will see at the start of 2019 is an number of Indian companies that will have been signed up, which all link in with our agreement with TATA. We are not just talking about the TATA deal, but other Indian partners to work right through India through a range of different companies, this is what large corporate's like your TATA's, P&G and Unilever want, because this is their route to market. These deals we hope to announce at the beginning of 2019 are all linked back to TATA, including another company as big as TATA we are in discussion with

[bernieboy] 07/1/2019 07:18

Shrewd it looks like it and that was my first thought. Liked the talk of new corporates too: 'the needs of existing and new corporate partners in India and Southern Asia and anticipate further announcements in due course'......splendid start to the week!

[shrewdmole] 07/1/2019 07:09

Precursor to more news re tata?

[shrewdmole] 07/1/2019 07:06

That’s huge.

Basically another first rate partner and I like the bit where it says Opti chose them!!!

Soh has been saying they have multiple approaches.

S

[aspex] 07/1/2019 07:04

Here we go!30m potential customers in India.

[judijudi] 07/1/2019 07:04

Another partner in India
:)

[thescoop] 06/1/2019 23:29

"The mad manc" clearly has the utmost respect for * all * you have to say Slarty, he surely wouldn't be doing it just to get the southerner out of his face for some peace and quiet, would he?! ;)Look after that back Sir, you don't want to disappoint 'er indoors ...

[slartybartfaster] 06/1/2019 16:23

At least i can claim to have influence over the mad manc. It was my suggestion he repost risky's essay on the lemming blog. He then followed it up with thescoop. lol

I have just taken a bow. Now my back has gone!

Scoop, don't worry, he prob got a mood on after a few too many troopers. He can't handle them as well as he likes to think he can. lol

[glennrcharles] 06/1/2019 16:20

Erm that was a smile not a question mark :)

[glennrcharles] 06/1/2019 16:20

Great stuff Elrico....?

[thescoop] 06/1/2019 14:17

It seems that elrico has quoted me in his latest blog post. Fame at last! :)El Rico, If you're reading this, i'd be very grateful if you would unblock me from following you on twitter. I'm not sure what I may have said to have offended you, I do apologise.Thank you for your insightful commentary, it's much appreciated!Rgds, Thescooptwitter : @ProfFoster_

[colinzeal] 06/1/2019 13:32

Would definitely like to see them vary the RNS days up a little, catch a few off-guard.

[rayrac] 06/1/2019 13:21

Optibiotix-lies-lies-and-dam-more-lies.html

[slartybartfaster] 06/1/2019 13:08

I nearly forgot. Just for you Mr Rayrac

[slartybartfaster] 06/1/2019 13:06

Tuesday is the preferred RNS day, rarely do we get anything on Monday. Annoying because it helps the traders plan their entry exit game play.I hope they get caught out with a blockbuster.

I live in hope.

[daveb23] 06/1/2019 11:37

Really hoping for big news that will happen this week. And fingers crossed that it happens tomorrow! SOH playing it well and is very cautious in his approach which is the best way to be! Let's see. Would be great start to 2019!

[rayrac] 06/1/2019 11:10

And still they ramp more rubbish. There’s nothing unique about Opti products...just a unique way of trying it on.

[parob] 06/1/2019 10:57

Just need SlimBiome Medical to be widely available in the UK together with some media coverage and it should really take off. Nothing else like it on the market!That's a front page story in The Sunday Times by the way.

[shrewdmole] 06/1/2019 10:48

It’s all about being in the right place at the right time.....

[parob] 06/1/2019 10:34

'Horrific' rise in obesity surgery threatens NHSJanuary 6 2019, 12:01am41,000 overweight patients got new hips and knees last year - including seven teenagershTTps://www.thetimes.co.uk/article/horrific-rise-in-obesity-surgery-threatens-nhs-f2xvzj8m7More than 41,000 obese people needed hip or knee replacement operations because of their condition last year - including seven teenage girls, The Sunday Times can reveal.Our investigation found that the numbers of obese patients who have had joint replacement surgery have soared six-fold in only eight years from 6,191 in 2009-10 to 41,761 in 2017-18.This 575% increase in operations now costs the NHS £200m a year.The figures underline the scale of Britain's weight problem but are a fraction of the spiralling £6bn cost of obesity to the NHS budget, which is already reeling under the burden of a rapidly expanding ageing population.

[owenmo] 06/1/2019 10:11

This week's Investor Chronicle update on Opti is significantly more positive than even they themselves seem to conclude. The coverage ends in reiterating previous caution that invites would-be investors to wait and see, whilst stating that existing holders may well be in for reward.However this overview conflicts with an earlier stated objective in the article along the lines that it would abandon stereotypical "buy" "sell" "hold" recommendations (given high-risk AIM setting) in favour of "sink" or "swim". Having rated one stock "sink" the article goes on: "contrastingly ...... Opti has negotiated a number of hurdles etc"? ... followed by very positive indicators. And so, logically what should have ensued was a resounding "swim" rating - inviting would-be investors, having regard to risk tolerance, to take the plunge now, or to await clearer (financial) promise. Extraordinary, really, to state intention to approach task from an unorthodox stance and then fall back into trap of convention. Had they advocated "swim" as very clearly flagged in the text, sny perceived negativity would have been silenced before the off.

[shrewdmole] 06/1/2019 10:05

Scoop and risky

Fantastic posts.

Risky you beat me to it about the testing subjects, the dosage and the added prowess of lpgos.

I’m sure soh was quoted in satin a doubling of the dose to 0.2g had more than a doubling effect eg it’s not pro rata.

Very pleased to be in such a disruptive health tech at the ground floor.

We await news but whilst we are waiting we have a US pharma spending millions to make lpldl a biopharmaceutical, partners spending millions on increased capacity and construction of new facilities and all the time we have minimal overheads as the deals just line up ready to be signed.